Literature DB >> 3537835

High altitude cerebral edema.

A J Hamilton, A Cymmerman, P M Black.   

Abstract

Acute mountain sickness (AMS) is usually a benign and self-limited illness that befalls previously healthy individuals who ascend rapidly to high altitude without sufficient acclimatization. In its more severe forms, AMS can progress to a life-threatening condition in which pulmonary or cerebral edema can occur singly or in concert. High altitude cerebral edema (HACE) is a little-known clinical entity that manifests itself by a perplexing array of both generalized and localized neurological symptoms and signs. Furthermore, the development of HACE in climbers offers a unique experimental situation in which to examine the effects of hypoxia on the central nervous system. The epidemiology and clinical picture of HACE are reviewed. In addition, the pathology and predominant pathophysiological mechanisms postulated to explain HACE are examined, and the present recommendations for the prevention and treatment of this dangerous and unusual form of brain swelling are discussed.

Entities:  

Mesh:

Year:  1986        PMID: 3537835     DOI: 10.1227/00006123-198611000-00024

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  3 in total

Review 1.  Diabetic Kidney Disease in Older People with Type 2 Diabetes Mellitus: Improving Prevention and Treatment Options.

Authors:  Ahmed H Abdelhafiz
Journal:  Drugs Aging       Date:  2020-08       Impact factor: 3.923

2.  The effect of elevated intracranial pressure on the vibrational response of the ovine head.

Authors:  M Stevanovic; G R Wodicka; J D Bourland; G P Graber; K S Foster; G C Lantz; W A Tacker; A Cymerman
Journal:  Ann Biomed Eng       Date:  1995 Nov-Dec       Impact factor: 3.934

3.  Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.

Authors:  A J Ellsworth; E F Meyer; E B Larson
Journal:  West J Med       Date:  1991-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.